J
Jeffrey V. Ravetch
Researcher at Rockefeller University
Publications - 310
Citations - 59480
Jeffrey V. Ravetch is an academic researcher from Rockefeller University. The author has contributed to research in topics: Antibody & Receptor. The author has an hindex of 110, co-authored 296 publications receiving 54829 citations. Previous affiliations of Jeffrey V. Ravetch include Bristol-Myers Squibb & Kettering University.
Papers
More filters
Journal ArticleDOI
Evidence for the participation of the Ssp-3 antigen in the invasion of nonphagocytic mammalian cells by Trypanosoma cruzi.
TL;DR: The results suggest that Ssp-3-bearing molecules participate in the process of parasite internalization.
Journal ArticleDOI
Hydronephrosis associated with antiurothelial and antinuclear autoantibodies in BALB/c-Fcgr2b-/-Pdcd1-/- mice
Taku Okazaki,Yumi Otaka,Jian Wang,Hiroshi Hiai,Toshiyuki Takai,Jeffrey V. Ravetch,Tasuku Honjo +6 more
TL;DR: Observations suggest cross talk between two immunoinhibitory receptors, FcγRIIB and PD-1, on the regulation of autoimmune diseases.
Journal ArticleDOI
T Cell Development in Mice Lacking All T Cell Receptor ζ Family Members (ζ, η, and FcεRIγ)
Elizabeth W. Shores,Masao Ono,Tsutomo Kawabe,Connie L. Sommers,Tom Tran,Kin Lui,Mark C. Udey,Jeffrey V. Ravetch,Paul E. Love +8 more
TL;DR: Examination of different T cell populations reveals that ζ/η and Fcγ have distinct expression patterns that correlate with their thymus dependency, suggesting that a possible function for the differential expression of ζ family proteins may be to impart distinctive signaling properties to TCR complexes expressed on specific Tcell populations.
Patent
Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
TL;DR: In this article, the authors present reagents, methods and systems for predicting the cytotoxic activity of an antibody or variant thereof comprising: determining a binding affinity of the antibody or a variant thereof to a Fc activating receptor; determining abinding affinity of a variant of the same antibody to an Fc inhibitory receptor; and calculating the ratio of said activating binding affinity to said inhibitory binding affinity (A/I ratio).
Journal ArticleDOI
Antibody fucosylation predicts disease severity in secondary dengue infection.
Stylianos Bournazos,Hoa Thi My Vo,Veasna Duong,Heidi Auerswald,Sowath Ly,Anavaj Sakuntabhai,Anavaj Sakuntabhai,Philippe Dussart,Tineke Cantaert,Jeffrey V. Ravetch +9 more
TL;DR: In this paper, the authors examined the Fab and Fc structures of anti-DENV antibodies from patients before and after infection and with variable disease outcomes and found that DENV infection induced a specific increase in immunoglobulin G1 (IgG1) afucosylation, and the levels of afucosity were predictive of dengue disease severity.